糖酵解
细胞生物学
氧化磷酸化
厌氧糖酵解
STAT蛋白
生物
酪氨酸磷酸化
贾纳斯激酶
车站3
信号转导
生物化学
新陈代谢
作者
Feilong Wang,Song Zhang,Ryoung‐Hoon Jeon,Ivan Vučković,Xintong Jiang,Amir Lerman,Clifford D.L. Folmes,Petras D. Dzeja,Joerg Herrmann
出处
期刊:EBioMedicine
[Elsevier BV]
日期:2018-02-13
卷期号:30: 303-316
被引量:295
标识
DOI:10.1016/j.ebiom.2018.02.009
摘要
Classical activation of M1 macrophages with lipopolysaccharide (LPS) is associated with a metabolic switch from oxidative phosphorylation to glycolysis. However, the generalizability of such metabolic remodeling to other modes of M1 macrophage stimulation, e.g. type II interferons (IFNs) such as IFNγ, has remained unknown as has the functional significance of aerobic glycolysis during macrophage activation. Here we demonstrate that IFNγ induces a rapid activation of aerobic glycolysis followed by a reduction in oxidative phosphorylation in M1 macrophages. Elevated glycolytic flux sustains cell viability and inflammatory activity, while limiting reliance on mitochondrial oxidative metabolism. Adenosine triphosphate (ATP) distributed by aerobic glycolysis is critical for sustaining IFN-γ triggered JAK (Janus tyrosine kinase)-STAT-1 (Signal Transducer and Activator of Transcription 1) signaling with phosphorylation of the transcription factor STAT-1 as its signature trait. Inhibition of aerobic glycolysis not only blocks the M1 phenotype and pro-inflammatory cytokine/chemokine production in murine macrophages and also human monocytes/macrophages. These findings extend on the potential functional role of immuno-metabolism from LPS- to IFNγ-linked diseases such as atherosclerosis and autoimmune disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI